CVS Health Corp said on Wednesday it would administer Eli Lilly & Co's experimental antibody treatment to COVID-19 patients in their homes and in long-term care facilities through a U.S.

PEMGARDA® (pemivibart) net product revenue of $13.1 million reported for Q3 2025, representing 41% growth year-over-year and 11% growth ...

Submitted a New Drug Application (NDA) for accelerated approval of bitopertin in erythropoietic protoporphyria (EPP) on September 29, 2025; ...

Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy, ...

One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic syndrome or ...

WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, today announced ...

Nextcure ( ($NXTC) ) has released its Q3 earnings. Here is a breakdown of the information Nextcure presented to its investors. NextCure, Inc. is a ...

Q3 2025 Earnings Call Transcript November 4, 2025 OmniAb, Inc. misses on earnings expectations. Reported EPS is $-0.14 EPS, ...

People diagnosed with advanced breast cancer in 2025 can expect to live for an extra six or seven months, compared to the ...

Zoetis Inc. trades at low valuations despite strong growth and pipeline. Click for my updated look at ZTS stock prospects ...

Hanmi Pharm has officially begun Phase 1 clinical trials for a "next-generation innovative obesity drug" that is the world's ...

The birds are an unlikely example of how public health fights have shifted political dynamics in ways the U.S. is influencing and reckoning with.